Sino Biopharmaceutical (OTCMKTS:SBMFF – Get Free Report) shares saw unusually-strong trading volume on Thursday . Approximately 2,000 shares changed hands during mid-day trading, an increase of 12% from the previous session’s volume of 1,781 shares.The stock last traded at $0.6370 and had previously closed at $0.6439.
Sino Biopharmaceutical Stock Performance
The business has a 50 day simple moving average of $0.65 and a 200-day simple moving average of $0.76.
Sino Biopharmaceutical Company Profile
Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.
The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.
Further Reading
- Five stocks we like better than Sino Biopharmaceutical
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
